Quarterly Report • Aug 13, 2025
Quarterly Report
Open in ViewerOpens in native device viewer

| Highlights 3 | |
|---|---|
| thyssenkrupp nucera in figures 4 | |
| Expectations for 2024/25 5 | |
| Earnings, asset and financial position 6 | |
| Segment reporting 8 | |
| Statement of financial position 9 | |
| Income statement 10 | |
| Cash flow statement 11 | |
| Adjustment in accordance with IAS 8.41f. 12 | |
| Financial calendar, imprint and disclaimer 13 | |
thyssenkrupp nucera reports decline in sales in both technology areas in the third quarter of 2024/25 – EBIT almost at the previous year's level thanks to improved gross margin in the gH2 segment
| in EUR millions | Q3 2023/241 | Q3 2024/25 | Change in % | 9M 2023/241 | 9M 2024/25 | Change in % |
|---|---|---|---|---|---|---|
| Earnings position | ||||||
| Order Intake | 271 | 63 | –77 | 522 | 241 | –54 |
| thereof: Order Intake gH2 | 220 | 13 | –94 | 341 | 23 | –93 |
| thereof: Order Intake CA | 51 | 50 | –3 | 181 | 218 | 21 |
| Sales | 237 | 184 | –22 | 609 | 663 | 9 |
| thereof: Sales gH2 | 134 | 103 | –23 | 350 | 377 | 8 |
| thereof: Sales CA | 103 | 81 | –21 | 259 | 286 | 11 |
| Gross margin | 26 | 26 | 1 | 60 | 76 | 26 |
| Research and development cost | –11 | –10 | –8 | –25 | –24 | –4 |
| EBIT | 2 | 0 | –97 | –13 | 4 | ++ |
| thereof: EBIT gH2 | –23 | –13 | 43 | –61 | –39 | 36 |
| thereof: EBIT CA | 25 | 13 | –48 | 47 | 43 | –10 |
| EBIT margin | 1% | 0% | –1%P | –2% | 1% | 3%P |
| Earnings before taxes | 9 | 3 | –63 | 6 | 17 | ++ |
| Net income | 7 | –2 | −− | –1 | 4 | ++ |
| Earnings per Share (in EUR) (Basic=diluted) |
0.05 | –0.01 | −− | –0.01 | 0.04 | ++ |
1The statement was adjusted (see chapter Adjustment in accordance with IAS 8,41f.)
| in EUR millions | Q3 2023/241 | Q3 2024/25 | Change in % | 9M 2023/241 | 9M 2024/25 | Change in % |
|---|---|---|---|---|---|---|
| Financial position | ||||||
| Cash flow from operating activities |
–45 | –3 | 92 | –49 | 32 | ++ |
| Cash flow from investing activities | –2 | –6 | −− | –8 | –17 | −− |
| Free Cashflow | –47 | –10 | 80 | –57 | 15 | ++ |
1The statement was adjusted (see chapter Adjustment in accordance with IAS 8,41f.)
| in EUR millions | Sept. 30, 2024 | June 30, 2025 | Change in % | |
|---|---|---|---|---|
| Net assets | ||||
| Net financial assets | 673 | 660 | –2 | |
| Total assets | 1,261 | 1,247 | –1 | |
| Equity | 754 | 754 | 0 | |
| Equity ratio | 60% | 60% | 1%P |
| Headcount | Sept. 30, 2024 June 30, 2025 |
Change in % | |
|---|---|---|---|
| Employees | |||
| Employees as of the reporting date |
1,012 | 1,093 | 8 |
On 15 July 2025, thyssenkrupp nucera issued an ad hoc statement based on preliminary business performance in the first nine months of 2024/25, specifying and partially raising the outlook for the most important financial performance indicators, sales and EBIT, published in the combined management report for 2023/24 and confirmed in the half-year financial report for 2024/25.
Against the backdrop of the economic conditions expected at the time of publication of this quarterly report and the underlying assumptions, we continue to consider this outlook to be appropriate.
We expect sales in between EUR 850 million and EUR 920 million (2023/24: EUR 862 million). We had previously anticipated sales to range from EUR 850 million and EUR 950 million.
At the segment level, we expect the Green Hydrogen (gH2) segment to generate sales in between EUR 450 million and EUR 510 million (2023/24: EUR 524 million). We had previously anticipated sales of EUR 450 million to EUR 550 million.
In the Chlor-Alkali (CA) segment, we continue to expect sales to come in between EUR 380 million and EUR 420 million (2023/24: EUR 338 million). Both the new build and service businesses are expected to contribute to this increase.
We expect EBIT at Group level to be range from EUR –7 million to EUR 7 million (2023/24: EUR –14 million). The original guidance range was between EUR –30 million and EUR 5 million.
In the gH2 segment, we expect EBIT to be between EUR –75 million and EUR –55 million (2023/24: EUR –76 million). Previously, we had anticipated an improvement in EBIT to a negative mid-double-digit million euro amount. An improved gross margin in the AWE business, as a result of a more profitable project mix, is contributing significantly to the expected increase in EBIT. Rising research and development expenses in the SOEC business, which is also included in this segment, will be more than offset.
In the CA segment, we expect EBIT to be positive at between EUR 55 million and EUR 75 million (2023/24: EUR 62 million). Previously, we had anticipated a positive EBIT in the mid-double-digit million euro range below the previous year's figure.
Overall, we therefore expect sales for the Group in fiscal year 2024/25 to be between EUR 850 million and EUR 920 million and EBIT between EUR –7 million and EUR 7 million. Sales and EBIT will be based on the execution of projects already contracted.
Order intake for thyssenkrupp nucera amounted to EUR 63 million in the third quarter of 2024/25, down 77% against the same period of the previous year (Q3 2023/24: EUR 271 million). Of this, EUR 13 million was attributable to the Green Hydrogen (gH2) segment (Q3 2023/24: EUR 220 million) and EUR 50 million to the Chlor-Alkali (CA) segment (Q3 2023/24: EUR 51 million). The order intake in the gH2 new-build business was affected by project postponements. In the same period last year, around EUR 200 million was recognised in order intake in connection with the Stegra project. In the CA segment, the order volume from the service business increased, driven in particular by projects in the Middle East, while orders in the new build business were below the previous year's level.
In the first nine months of 2024/25, order intake amounted to EUR 241 million, a decline of 54% compared to the previous year (9M 2023/24: EUR 522 million). The gH2 segment accounted for EUR 23 million (9M 2023/24: EUR 341 million) and the CA segment for EUR 218 million (9M 2023/24: EUR 181 million). The decline in the gH2 segment is attributable to project postponements. In the same period of the previous year, more than EUR 300 million was also recorded in order intake in connection with the Stegra project. The increase in the CA segment is attributable to the service business, with Central Europe, the USA, China and the Middle East as the largest markets. By contrast, order intake from new build remained below the level of the same period of the previous year.
The order backlog as of 30 June 2025 amounted to EUR 0.7 billion (30 June 2024: EUR 1.3 billion), of which EUR 0.3 billion were attributable to gH2 business (30 June 2024: EUR 0.9 billion) and EUR 0.3 billion to the CA business (30 June 2024: EUR 0.4 billion). The decline in the order backlog is due to progress in project execution, which is also reflected in the sales growth for the nine-month period.
Sales in the third quarter of 2024/25 amounted to EUR 184 million, representing a decline of 22% compared to the same quarter of the previous year (Q3 2023/24: EUR 237 million). The sales development reflects the high level of completion of contractually agreed projects in both technology areas. In the gH2 segment, thyssenkrupp nucera recorded a 23% decline in sales to EUR 103 million (Q3 2023/24: EUR 134 million). The ongoing completion of the Stegra project in Sweden had a positive effect, while sales from the NEOM project in Saudi Arabia declined year-on-year due to the high level of completion already achieved. Sales in the CA segment amounted to EUR 81 million, representing a decline of 21% (Q3 2023/24: EUR 103 million). Sales declined in both, the new-build and the service business.
In the first nine months of 2024/25, sales reached EUR 663 million, representing an increase of 9% compared to the same period last year (9M 2023/24: EUR 609 million). The increase in sales is attributable to ongoing project execution in both segments. Sales in the gH2 segment grew to EUR 377 million (9M 2023/24: EUR 350 million). The increase in sales in the gH2 segment is primarily attributable to progress in the execution of the Stegra project in Sweden. The NEOM project in Saudi Arabia continued to contribute the largest share to segment sales, but was already declining compared to the same period last year. Sales in the CA segment increased to EUR 286 million (9M 2023/24: EUR 259 million). Both the new-build business and the service business improved.
Earnings before interest and taxes (EBIT) decreased by EUR –2 million to EUR 0 million in the third quarter of 2024/25 (Q3 2023/24: EUR 2 million). EBIT in the gH2 segment rose to EUR 13 million (Q3 2023/24: EUR –23 million), while EBIT in the CA segment fell to EUR 13 million (Q3 2023/24: EUR 25 million). The increase in EBIT in the gH2 segment is mainly attributable to an improved gross margin in the AWE business as a result of a more profitable project mix. EBIT in the CA segment declined due to the negative sales development and a lower gross margin in the execution of existing projects. In the same quarter of the previous year, EBIT in the CA segment also benefited from positive one-off effects.
In the first nine months of 2024/25, earnings before interest and taxes (EBIT) rose by EUR 17 million to EUR 4 million (9M 2023/24: EUR –13 million). EBIT in the gH2 segment was EUR –39 million (9M 2023/24: EUR –61 million) and in the CA segment EUR 43 million (9M 2023/24: EUR 47 million). As in the third quarter, the increase in EBIT at Group level is mainly attributable to an improved gross margin in the AWE division of the gH2 segment as a result of a more profitable project mix. In the CA segment, the increase in revenue was more than offset by a lower gross margin on existing projects. In addition, EBIT in the same period of the previous year benefited from positive one-off effects.
In the third quarter of 2024/25, the financial result was EUR 3 million (Q3 2023/24: EUR 7 million). The decline against previous year was driven by lower interest income due to lower interest rates. After income taxes, the result from continuing operations declined to EUR –2 million (Q3 2023/24: EUR 7 million). Earnings per share attributable to thyssenkrupp nucera shareholders decreased accordingly to EUR –0.01 (Q3 2023/24: EUR 0.05). In the first nine months of 2024/25, the financial result was 13 million (9M 2023/24: EUR 19 million). After income taxes, the result from continuing operations amounted to EUR 4 million (9M 2023/24: EUR –1 million). Earnings per share attributable to thyssenkrupp nucera shareholders rose accordingly to EUR 0.04 (9M 2023/24: EUR –0.01).
Net financial assets are calculated as the balance of cash and cash equivalents and financial assets less current debt instruments and non-current and current financial liabilities (including lease liabilities in accordance with IFRS 16). As of 30 June 2025, thyssenkrupp nucera reported net financial assets of EUR 660 million (30 September 2024: EUR 673 million).
Cash flow from operating activities in the third quarter of 2024/25 was EUR –3 million, up on the previous year (Q3 2023/24: EUR –45 million). In the first nine months of 2024/25, cash flow from operating activities was also above the prior-year figure at EUR 32 million (9M 2023/24: –49 million). This was primarily due to the reduction in contract assets and trade receivables as projects progressed, while these items had increased in the same period of the previous year. Reduced contract liabilities and trade payables led to cash outflows and a further increase in inventories to secure the supply chain.
Cash flow from investing activities amounted to EUR –6 million (Q3 2023/24: EUR –2 million). In the first nine months of 2024/25, cash flow from investing activities amounted to EUR –17 million (9M 2023/24: EUR –8 million).
In the third quarter of 2024/25, cash flow from financing activities was EUR –1 million, on par with the previous year (Q3 2023/24: EUR –1 million). In the first nine months of 2024/25, cash flow from financing activities amounted to EUR –3 million. Cash outflows were thus lower than in the same period of the previous year (9M 2023/24: EUR –7 million).
The segment structure was changed as of the 2024/25 fiscal year and is aligned with the technological applications of thyssenkrupp nucera. Since October 2024, the management of the company's activities, differentiated until September 30, 2024 into the segments Germany, Italy, Japan, China and RoW (Rest of World), has been carried out in the two segments Chlor-Alkali Electrolysis (CA) and Green Hydrogen (gH2). The gH2 segment includes alkaline water electrolysis (AWE) and solid oxide electrolysis cells (SOEC).
The new segment structure reflects the company's strategic orientation and enables technology-based reporting across the two main business areas. The previous year's figures have been adjusted to the new segment reporting to improve comparability.
A detailed description of the development of the individual segments is provided in the earnings report.
| Q3 2023/24 | ||||
|---|---|---|---|---|
| in EUR millions | Green Hydrogen (gH2) | Chlor-Alkali (CA) | Group | |
| Sales | 134 | 103 | 237 | |
| EBIT | –23 | 25 | 2 | |
| Thereof depreciation | 1 | 1 | 1 |
| Q3 2024/25 | |||
|---|---|---|---|
| in EUR millions | Green Hydrogen (gH2) | Chlor-Alkali (CA) | Group |
| Sales | 103 | 81 | 184 |
| EBIT | –13 | 13 | 0 |
| Thereof depreciation | 2 | 1 | 3 |
| in EUR millions | Green Hydrogen (gH2) | Chlor-Alkali (CA) | Group |
|---|---|---|---|
| Sales | 350 | 259 | 609 |
| EBIT | –61 | 47 | –13 |
| Thereof depreciation | 2 | 2 | 4 |
| in EUR millions | Green Hydrogen (gH2) | Chlor-Alkali (CA) | Group |
|---|---|---|---|
| Sales | 377 | 286 | 663 |
| EBIT | –39 | 43 | 4 |
| Thereof depreciation | 5 | 3 | 8 |
| in EUR millions | Sept. 30, 2024 | June 30, 2025 |
|---|---|---|
| Property, plant and equipment | 14 | 41 |
| Goodwill | 55 | 53 |
| Intangible assets other than goodwill | 7 | 16 |
| Other financial assets | 0 | 0 |
| Other non-financial assets | 3 | 4 |
| Deferred tax assets | 29 | 28 |
| Total non-current assets | 108 | 142 |
| Inventories | 147 | 199 |
| Trade accounts receivable | 63 | 69 |
| Contract assets | 122 | 68 |
| Other financial assets | 3 | 4 |
| Other non-financial assets | 132 | 69 |
| Current income tax assets | 6 | 8 |
| Cash and cash equivalents | 680 | 688 |
| Total current assets | 1,153 | 1,105 |
| Total assets | 1,261 | 1,247 |
| in EUR millions | Sept. 30, 2024 | June 30, 2025 |
|---|---|---|
| Capital stock | 126 | 126 |
| Additional paid-in capital | 506 | 506 |
| Retained earnings | 126 | 130 |
| Cumulative other comprehensive income | –4 | –8 |
| Equity attributable to thyssenkrupp nucera Group equity holders | 754 | 754 |
| Accrued pension and similar obligations | 9 | 8 |
| Provisions for other non-current employee benefits | 0 | 0 |
| Other provisions | 1 | 0 |
| Deferred tax liabilities | 13 | 13 |
| Lease liabilities, non-current | 3 | 25 |
| Other financial liabilities | 1 | – |
| Total non-current liabilities | 27 | 48 |
| Provisions for current employee benefits | 5 | 6 |
| Other provisions | 56 | 73 |
| Current income tax liabilities | 5 | 8 |
| Lease liabilities, current | 2 | 4 |
| Trade accounts payable | 163 | 136 |
| Other financial liabilities | 4 | 3 |
| Contract liabilities | 225 | 199 |
| Other non-financial liabilities | 20 | 17 |
| Total current liabilities | 480 | 445 |
| Total liabilities | 507 | 493 |
| Total equity and liabilities | 1,261 | 1,247 |
| in EUR millions | Q3 2023/241 | Q3 2024/25 | 9M 2023/241 | 9M 2024/25 |
|---|---|---|---|---|
| Sales | 237 | 184 | 609 | 663 |
| Cost of sales | –212 | –158 | –549 | –587 |
| Gross margin | 26 | 26 | 60 | 76 |
| Research and development cost | –11 | –10 | –25 | –24 |
| Selling expenses | –6 | –5 | –17 | –14 |
| General and administrative expenses | –12 | –14 | –39 | –42 |
| Other income | 6 | 4 | 9 | 10 |
| Other expenses | 0 | –1 | –2 | –2 |
| EBIT | 2 | 0 | –13 | 4 |
| Finance income | 7 | 5 | 21 | 18 |
| Finance expenses | 0 | –1 | –2 | –5 |
| Financial income/(expense), net | 7 | 3 | 19 | 13 |
| Earnings before taxes | 9 | 3 | 6 | 17 |
| Income tax expense | –2 | –5 | –6 | –13 |
| Net income | 7 | –2 | –1 | 4 |
| Thereof: thyssenkrupp nucera KGaA's equity holders | 7 | –2 | –1 | 4 |
| Earnings per Share (in EUR) (Basic=diluted) |
0.05 | –0.01 | –0.01 | 0.04 |
| Weighted average of outstanding shares (in million units) | 126 | 126 | 126 | 126 |
1The statement was adjusted (see chapter Adjustment in accordance with IAS 8,41f.)
| in EUR millions | Q3 2023/241 | Q3 2024/25 | 9M 2023/241 | 9M 2024/25 |
|---|---|---|---|---|
| Net income | 7 | –2 | –1 | 4 |
| Adjustments to reconcile net income/(loss) to operating cash flows: |
||||
| Deferred income taxes, net | –2 | 1 | –1 | 0 |
| Depreciation, amortization and impairment of non-current as sets |
1 | 3 | 4 | 8 |
| Changes in assets and liabilities, net of non-cash effects: | ||||
| – Inventories | 1 | –23 | –25 | –56 |
| – Trade accounts receivable | –46 | –3 | –36 | –8 |
| – Contract assets | –32 | 40 | –74 | 55 |
| – Accrued pension and similar obligations | 0 | 0 | 0 | 1 |
| – Other provisions | 13 | 8 | 17 | 18 |
| – Trade accounts payable | 22 | –21 | 32 | –24 |
| – Contract liabilities | –8 | –35 | 35 | –24 |
| – Other assets/liabilities not related to investing or financing activities |
–2 | 30 | –1 | 57 |
| Cash flow from operating activities | –45 | –3 | –49 | 32 |
| Expenditures for acquisitions of consolidated companies net of cash acquired |
– | – | –3 | – |
| Capital expenditures from property, plant and equipment (inclusive of advance payments) |
–1 | –3 | –2 | –7 |
| Capital expenditures for intangible assets (inclusive of advance payments) |
–1 | –4 | –2 | –10 |
| Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets |
0 | 0 | 0 | 0 |
| Cash flow from investing activities | –2 | –6 | –8 | –17 |
| Cash flows from redemption of lease liabilities | –1 | –1 | –2 | –3 |
| Cost of capital procurement | – | – | –4 | – |
| Other financial activities | – | – | 0 | 0 |
| Cash flow from financing activities | –1 | –1 | –7 | –3 |
| Net increase/(decrease) in cash and cash equivalents | –48 | –11 | –63 | 12 |
| Effect of exchange rate changes on cash and cash equivalents | –1 | –3 | –4 | –3 |
| Cash and cash equivalents at beginning of year | 750 | 702 | 767 | 680 |
| Cash and cash equivalents at end of year | 700 | 688 | 700 | 688 |
| Additional information regarding income tax amounts included in operating cash flows: |
||||
| Income tax paid | –6 | –7 | –11 | –11 |
| Interest received | 7 | 4 | 19 | 15 |
| Interest paid | 0 | 0 | 0 | –1 |
1The statement was adjusted (see chapter Adjustment in accordance with IAS 8,41f.)
In the financial year 2023/24, there was an adjustment to the accounting treatment of contracts with customers in accordance with IFRS 15 and of provisions in accordance with IAS 37. In this context, the comparative figures for the third quarter of 2023/24 were adjusted.
This was due to a change in the accounting treatment of customer contracts: costs of warranty and guarantee obligations are no longer included in the total expected contract costs under IFRS 15 and therefore no longer affect the percentage of completion determined using the cost-to-cost method. Along with this change, the creation of provisions for warranties and guarantees is now also carried out in line with the progress of performance according to the degree of completion and is built up in corresponding instalments over the period of the order processing.
In addition to the adjustment regarding warranties and guarantees in accordance with IAS 8.41f., further immaterial items in the previous year's figures were adjusted accordingly in line with IAS 8.41f.
The correction in accordance with IAS 8.41f. had the following effects on the income statement for the nine-month period of 2023/24 (9M 2023/24), which result entirely from the described adjustment to the accounting treatment of customer contracts and the accounting treatment of warranty and guarantee obligations:
In addition, the following effects on the cash flow statement for the nine-month period of 2023/24 (9M 2023/24) were recognized in the reconciliation statement within the cash flow from operating activities, resulting entirely from the adjustment of the accounting treatment of customer contracts and the accounting treatment of warranty and guarantee obligations:
This had no impact on cash flow from operating activities, cash flow from investing activities, cash flow from financing activities or cash and cash equivalents in the statement of cash flows.
There were no effects on the balance sheet as of September 30, 2024, as the corrections described were implemented within the fiscal year 2023/24.
17 December 2025 | Annual Report 2024/2025
| Imprint | Contact | ||
|---|---|---|---|
| thyssenkrupp nucera AG & Co. KGaA | Investor Relations | ||
| Freie-Vogel-Str. 385 a | Phone: +49 231 229 724 347 | ||
| 44269 Dortmund | E-Mail: [email protected] | ||
| www.thyssenkrupp-nucera.com | |||
| Communications | |||
| Publication Date | Phone: +49 172 149 25 42 |
13 February 2025, 07:00 am CET E-Mail: [email protected]
Produced in-house using firesys.
This document is a quarterly report pursuant to Section 53 of the Stock Exchange Regulations for the Frankfurt Stock Exchange.
This report contains forward-looking statements based on current expectations, assumptions and forecasts of the Management Board and the information currently available to it. The forward-looking statements are not to be understood as guarantees of the future developments and results mentioned therein. Rather, future developments and results depend on a variety of factors; they involve various risks and uncertainties and are based on assumptions that may not prove to be accurate. Therefore, actual results may differ materially from those expressed or implied by the forward-looking statements contained in this financial report. The forward-looking statements contained in this financial report will not be updated in the light of events or developments occurring after the date of the report.
This document is available in German and English. In the event of variances, the German version shall take precedence over the English translation.
Percentages and figures in this report may include rounding differences. Negative absolute values in the tables are shown in brackets ( ). The signs used to indicate rates of change are based on economic aspects: Improvements are indicated by positive percentage; deteriorations are shown by a minus (−) sign. Very high positive and negative rates of change (≥ +100% or ≤ -100%) are indicated by ++ and −− respectively.
Have a question? We'll get back to you promptly.